Stock price when the opinion was issued
Future? Produces plant-based medicine. They’re smart, likes the management team because of their pharma experience. Oversupply still to get through, but if you’re willing to look beyond the next year, stick with it. If you’re worried about storm clouds, put your money into a high-yielding energy stock, or another commodity, and then come back in later in 2019.
It does look interesting. They have an expansion plan. He thinks the caller might be onto something. He would not run out and buy it because the valuation is still $150 Million.